4-Acetoxy-MiPT

4-Acetoxy-MiPT
Names
Preferred IUPAC name
3-{2-[Methyl(propan-2-yl)amino]ethyl}-1H-indol-4-yl acetyl
Other names
Mipracetin
Identifiers
CAS Number
3D model (JSmol)
ChemSpider
PubChem CID
UNII
InChI
  • InChI=1S/C16H22N2O2/c1-11(2)18(4)9-8-13-10-17-14-6-5-7-15(16(13)14)20-12(3)19/h5-7,10-11,17H,8-9H2,1-4H3 checkY
    Key: CIDMXLOVFPIHDS-UHFFFAOYSA-N checkY
  • InChI=1/C16H22N2O2/c1-11(2)18(4)9-8-13-10-17-14-6-5-7-15(16(13)14)20-12(3)19/h5-7,10-11,17H,8-9H2,1-4H3
    Key: CIDMXLOVFPIHDS-UHFFFAOYAP
SMILES
  • CC(N(CCC1=CNC2=C1C(OC(C)=O)=CC=C2)C)C
Properties
Chemical formula
C16H22N2O2
Molar mass 274.364 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

4-AcO-MiPT (4-acetoxy-N-methyl-N-isopropyltryptamine or mipracetin) is a psychedelic tryptamine. It is closely related to O-acetylpsilocin and MiPT.

There is very little information on the human pharmacology or toxicity of 4-AcO-MiPT, although analytical methods have been developed for its detection.[1][2]

Drug prohibition laws

Sweden

Sveriges riksdags health ministry Statens folkhälsoinstitut classified 4-AcO-MiPT as "health hazard" under the act Lagen om förbud mot vissa hälsofarliga varor (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of Nov 1, 2005, in their regulation SFS 2005:733 listed as 4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT), making it illegal to sell or possess.[3]

References

  1. TAKAHASHI, M; NAGASHIMA, M; SUZUKI, J; SETO, T; YASUDA, I; YOSHIDA, T (15 February 2009). "Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry". Talanta. 77 (4): 1245–1272. doi:10.1016/j.talanta.2008.07.062. PMID 19084633.
  2. Noorizadeh, Hadi; Farmany, Abbas; Noorizadeh, Mehrab (20 September 2011). "Application of GA–KPLS and L–M ANN calculations for the prediction of the capacity factor of hazardous psychoactive designer drugs". Medicinal Chemistry Research. 21 (9): 2680–2688. doi:10.1007/s00044-011-9794-y. S2CID 16413083.
  3. http://www.notisum.se/rnp/sls/sfs/20050733.pdf
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.